Compare Summit Therapeutics Inc (SMMT) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs AT&T Inc. — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while AT&T Inc. trades at $22.3 (market cap $152.52B). The key difference: AT&T Inc. is far larger — about 14.6× Summit Therapeutics Inc's market cap, and AT&T Inc. pays a 5.06% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | T | |
|---|---|---|
Market Cap | $10.48B | $152.52B |
Sector | Health | Media |
52-Week High | $29.32 | $29.62 |
52-Week Low | $13.05 | $20.49 |
Enterprise Value | $9.90B | $297.87B |
Dividend Yield | — | 5.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
